Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints

被引:5
作者
Gou, Jiangtao [1 ]
机构
[1] Villanova Univ, Dept Math & Stat, Villanova, PA 19085 USA
关键词
multiple tests; multistage designs; power; sample size; trigger; CLOSED TESTING PROCEDURES; CLINICAL-TRIALS; DESIGN; BONFERRONI; FRAMEWORK; FAMILY; SIMES; POWER;
D O I
10.1002/bimj.202000081
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider multistage tests of multiple hypotheses under a flexible setting of calendar time and information fraction, focusing on the case where there are two hypotheses under testing. Explicit expressions of statistical powers are derived. With a proof of existence and uniqueness of solution, we develop a numerical method to search the optimal sample size. The proposed method allows us to find the suitable allocation of initial significance level along with the minimum sample size for group sequential designs, with and without hierarchical structures among different endpoints.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 50 条
  • [31] Efficient and flexible simulation-based sample size determination for clinical trials with multiple design parameters
    Wilson, Duncan T.
    Hooper, Richard
    Brown, Julia
    Farrin, Amanda J.
    Walwyn, Rebecca E. A.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (03) : 799 - 815
  • [32] Power and sample size considerations in clinical trials with competing risk endpoints
    Maki, Ellen
    PHARMACEUTICAL STATISTICS, 2006, 5 (03) : 159 - 171
  • [33] Blinded sample size recalculation in clinical trials with binary composite endpoints
    Sander, Anja
    Rauch, Geraldine
    Kieser, Meinhard
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (04) : 705 - 715
  • [34] Overestimation of the Effect Size in Group Sequential Trials
    Zhang, Jenny J.
    Blumenthal, Gideon M.
    He, Kun
    Tang, Shenghui
    Cortazar, Patricia
    Sridhara, Rajeshwari
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4872 - 4876
  • [35] Sequential monitoring of covariate adaptive randomized clinical trials with sample size re-estimation
    Yu, Jun
    Lai, Dejian
    CONTEMPORARY CLINICAL TRIALS, 2019, 87
  • [36] Cluster randomised trials with different numbers of measurements at baseline and endline: Sample size and optimal allocation
    Copas, Andrew J.
    Hooper, Richard
    CLINICAL TRIALS, 2020, 17 (01) : 69 - 76
  • [37] Sample size calculation in clinical trials with two co-primary endpoints including overdispersed count and continuous outcomes
    Homma, Gosuke
    Yoshida, Takuma
    PHARMACEUTICAL STATISTICS, 2024, 23 (01) : 46 - 59
  • [38] Multiple Testing in Group Sequential Trials Using Graphical Approaches
    Maurer, Willi
    Bretz, Frank
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2013, 5 (04): : 311 - 320
  • [39] A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs
    Knahl, Sophie I. E.
    Lang, Benjamin
    Fleischer, Frank
    Kieser, Meinhard
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (05) : 549 - 559
  • [40] Bayesian Sample Size Calculation in Small n, Sequential Multiple Assignment Randomized Trials (snSMART)
    Fang, Fang
    Tamura, Roy N.
    Braun, Thomas M.
    Kidwell, Kelley M.
    PHARMACEUTICAL STATISTICS, 2025, 24 (01)